Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 16/20 | 0.68 |
| ▸ | GABRB3 | P28472 | 16/20 | 0.68 |
| ▸ | GABRA5 | P31644 | 16/20 | 0.68 |
| ▸ | GABRA3 | P34903 | 16/20 | 0.68 |
| ▸ | GABRA1 | P14867 | 8/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21117285 | 0.91 | GABRG2 (0.56) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117707 | 0.91 | GABRG2 (0.60) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117473 | 0.88 | GABRG2 (0.53) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117329 | 0.88 | GABRG2 (0.60) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117486 | 0.87 | GABRG2 (0.68) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117708 | 0.84 | GABRG2 (0.55) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117325 | 0.84 | GABRG2 (0.51) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117485 | 0.83 | GABRG2 (0.54) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL221868 | 0.82 | GABRG2 (1.00) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL21117501 | 0.81 | GABRG2 (0.47) | GABRG2GABRB3GABRA5GABRA3GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-20190194237-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194237-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | ORC3, LEF1, OCIAD1 | GABRG2 3680/4885GABRB3 4274/4885GABRA5 3944/4885 |
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | ORC3, LEF1, OCIAD1 | GABRG2 3680/4885GABRB3 4274/4885GABRA5 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.